2seventy bio Company
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Technology:
CAR-T therapy, Cell-based gene therapy
Industry:
Public
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
2021-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
15
Total Funding:
315000000
Last Funding Date:
2023-02-28
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership